{
    "pubmed_id": 35180044,
    "study_identifier": "PMID35180044_study-01",
    "study_name": "Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma",
    "publication_title": "Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma",
    "study_objective": "Despite animal studies showing decreased vaccine-induced humoral immunity   there is a paucity of literature available in asthma patient population following SARS-CoV-2 vaccination.",
    "study_description": "It is unclear if patients with severe asthma and atopic dermatit is on biologic therapies have an adequate and durable humoral immune response after vaccination to SARS-CoV-2. To address these questions, we conducted a prospective observational trial from February 2021 to September 2021 with adults who had severe asthma or atopic dermatitis treated with benralizumab (IL-5 receptor antagonist), mepolizumab(IL-5 antagonist), or dupilumab (IL-4 receptor a antagonist).",
    "primary_institution_name": "Emory University",
    "study_personnel": [
        {
            "personnel_id": "PMID35180044_personnel-01",
            "honorific": "",
            "last_name": "Lee",
            "first_name": "F. Eun-Hyung",
            "suffixes": "",
            "organization": "Emory University",
            "orchid_id": "",
            "email": "f.e.lee@emory.edu",
            "seronet_title_in_study": "Seronet Investigator",
            "role_in_study": "Principal Investigator",
            "site_name": "Emory University"
        },
        {
            "personnel_id": "PMID35180044_personnel-02",
            "honorific": "",
            "last_name": "Sanz",
            "first_name": "Ignacio",
            "suffixes": "",
            "organization": "Emory University",
            "orchid_id": "",
            "email": "ignacio.sanz@emory.edu",
            "seronet_title_in_study": "SeroNet Principal Investigator",
            "role_in_study": "other",
            "site_name": "Emory University"
        }
    ],
    "study_file": [
        {
            "study_file_name": "ICMJE Disclosure Form",
            "study_file_description": "Disclosure",
            "study_file_type": "Other"
        },
        {
            "study_file_name": "Biologic vaccine study.xlsx",
            "study_file_description": "Study data",
            "study_file_type": "Study Data"
        },
        {
            "study_file_name": "PMID35180044_v1.2.6.xlsm",
            "study_file_description": "Completed curation of the study into SeroNet Registry Template which includes SeroNet Study Descriptors",
            "study_file_type": "Study Summary Description"
        }
    ],
    "study_link": [],
    "research_focus": "Vaccine Response",
    "study_type": "Clinical Research",
    "keyword": [
        "Anti-Asthmatic Agents / therapeutic use",
        "Asthma / drug therapy",
        "Biological Therapy",
        "COVID-19 Vaccines / therapeutic use",
        "COVID-19",
        "Humans"
    ],
    "clinical_study_design": "Prospective Cohort",
    "in_silico_model_type": "",
    "protocol": {
        "protocol_id": "PMID35180044_protocol-01",
        "protocol_file_name": "PMID35180044_protocol-01.txt",
        "protocol_name": "PMID35180044_protocol-01",
        "protocol_description": "Study Protocol",
        "protocol_type": "Study Protocol"
    },
    "reported_health_condition": [
        "Covid-19",
        "Asthma",
        "Atopic Dermatitis"
    ],
    "sars_cov_2_vaccine_type": [
        "Pfizer-BioNTech SARS-CoV-2 vaccine",
        "Moderna SARS-CoV-2 vaccine"
    ],
    "clinical_outcome_measure": "",
    "enrollment_start_date": "2021-02-01",
    "enrollment_end_date": "2021-09-01",
    "number_of_study_subjects": 84,
    "age_unit": "Years",
    "minimum_age": 18,
    "maximum_age": 78,
    "study_human_cohort": [
        {
            "arm_id": "PMID35180044_human_subject-01",
            "arm_name": "Adults with severe asthma or atopic dermatitis",
            "study_population_description": "Adults with severe asthma or atopic dermatitis treated with benralizumab, mepolizumab, or dupilumab",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "United States of America"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine ; VO:0004987",
                "Moderna COVID-19 vaccine ; VO:0005157"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        },
        {
            "arm_id": "PMID35180044_human_subject-02",
            "arm_name": "Healthy adults",
            "study_population_description": "Healthy Adults",
            "arm_type": "Observational",
            "ethnicity": [
                "Not Specified"
            ],
            "race": [
                "Not Specified"
            ],
            "race_specify": [],
            "description": "",
            "sex_at_birth": [
                "Female",
                "Male"
            ],
            "age_event": "Age at enrollment",
            "subject_phenotype": "",
            "assessment_name": [],
            "study_location": [
                "United States of America"
            ],
            "measured_behavioral_or_pyschological_factor": [],
            "measured_social_factor": [],
            "sars_cov_2_symptoms": [],
            "assessment_clinical_and_demographic_data_provenance": [],
            "assessment_demographic_data_types_collected": [],
            "sars_cov_2_history": [
                "Uninfected"
            ],
            "sars_cov_2_vaccine_type": [
                "Pfizer BioNTech COVID-19 vaccine ; VO:0004987",
                "Moderna COVID-19 vaccine ; VO:0005158"
            ],
            "covid_19_disease_severity": [],
            "post_covid_19_symptoms": [],
            "covid_19_complications": []
        }
    ],
    "study_model_cohort": [],
    "planned_visit": [
        {
            "visit_id": "PMID35180044_visit-01",
            "visit_name": "1st Blood sample after second dose",
            "visit_order_number": 1,
            "visit_min_start_day": 25,
            "visit_max_start_day": 49,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35180044_visit-02",
            "visit_name": "2nd Blood sample after second dose",
            "visit_order_number": 2,
            "visit_min_start_day": 50,
            "visit_max_start_day": 74,
            "visit_start_rule": ""
        },
        {
            "visit_id": "PMID35180044_visit-03",
            "visit_name": "3rd Blood sample after second dose",
            "visit_order_number": 3,
            "visit_min_start_day": 75,
            "visit_max_start_day": 99,
            "visit_start_rule": ""
        }
    ],
    "experiment": [
        {
            "arm_id": [
                "PMID35180044_human_subject-01"
            ],
            "associated_first_planned_visit_id": [
                "PMID35180044_visit-01"
            ],
            "assay_type": "Multiplex Bead Array Assay",
            "experiment_name": "multiplex Luminex assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-vaccination"
            ],
            "sars_cov_2_antigen": [
                "Receptor Binding Domain (RBD)"
            ],
            "assay_use": "Commercial Test",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "Other",
                "IgG"
            ],
            "reporting_units": "Other",
            "assay_reporting_format": "Quantitative"
        },
        {
            "arm_id": [
                "PMID35180044_human_subject-02"
            ],
            "associated_first_planned_visit_id": [
                "PMID35180044_visit-02"
            ],
            "assay_type": "Multiplex Bead Array Assay",
            "experiment_name": "multiplex Luminex assay",
            "experiment_results_file_name": "na",
            "biospecimen_type": [
                "Blood"
            ],
            "biospecimen_collection_point": [
                "Post-vaccination"
            ],
            "sars_cov_2_antigen": [
                "N-terminal Domain (NTD)",
                "S1",
                "S2",
                "Nucleocapsid",
                "Other"
            ],
            "assay_use": "Commercial Test",
            "manufacture": "components from multiple manufacturers",
            "catalog_number": "",
            "virus_target": [
                "SARS-CoV-2"
            ],
            "antibody_isotype": [
                "IgG"
            ],
            "reporting_units": "Other",
            "assay_reporting_format": "Quantitative"
        }
    ],
    "geriatric_subjects": "No",
    "pediatric_subjects": "No",
    "pregnant_subjects": "Not Specified",
    "sars_cov_2_antibodies_measured": "No",
    "survey_instrument_shared": "Not Specified",
    "who_disease_severity_scale_used": "Not Specified",
    "inclusion_exclusion": [
        {
            "inclusion_exculusion_id": "PMID35180044_inexcl-01",
            "inclusion_criterion": "Geriatric subjects",
            "inclusion_criterion_category": "Yes"
        },
        {
            "inclusion_exculusion_id": "PMID35180044_inexcl-02",
            "inclusion_criterion": "Pediatric subjects",
            "inclusion_criterion_category": "No"
        },
        {
            "inclusion_exculusion_id": "PMID35180044_inexcl-03",
            "inclusion_criterion": "SARS-CoV-2 Antibodies Measured",
            "inclusion_criterion_category": "Yes"
        }
    ]
}
